Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
The risks that can come from buying these assets are precisely why we started StockStory — to isolate the long-term winners from the losers so you can invest with confidence. Keeping that in mind, here are two growth stocks with significant upside potential and one whose momentum may slow.
One Growth Stock to Sell:
Genesis Energy (GEL)
One-Year Revenue Growth: +16.6%
Operating a 64% stake in the Poseidon Pipeline, one of the Gulf of Mexico's largest crude oil pipelines, Genesis Energy (NYSE: GEL) provides midstream services like pipeline transportation, storage, and processing for crude oil and natural gas producers and refiners.
Why Do We Pass on GEL?
- Flat sales over the last five years suggest it must find different ways to grow during this cycle
- High extraction costs and unfavorable asset economics are reflected in its low gross margin of 25.8%
- 5× net-debt-to-EBITDA ratio makes lenders less willing to extend additional capital, potentially necessitating dilutive equity offerings
Genesis Energy’s stock price of $15.06 implies a valuation ratio of 8x forward EV-to-EBITDA. If you’re considering GEL for your portfolio, see our FREE research report to learn more.
Two Growth Stocks to Watch:
iRhythm (IRTC)
One-Year Revenue Growth: +25.6%
Pioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ: IRTC) provides wearable cardiac monitoring devices and AI-powered analysis services that help physicians detect and diagnose heart rhythm disorders.
Why Is IRTC Interesting?
- Annual revenue growth of 24% over the last two years was superb and indicates its market share increased during this cycle
- Earnings per share have massively outperformed its peers over the last five years, increasing by 17.4% annually
- Free cash flow profile has moved into positive territory over the last five years, indicating the company has achieved financial self-sustainability
At $137.99 per share, iRhythm trades at 216.1x forward P/E. Is now a good time to buy? See for yourself in our in-depth research report, it’s free.
Everpure (P)
One-Year Revenue Growth: +21%
Founded in 2009 as a pioneer in enterprise all-flash storage technology, Everpure (NYSE: P) provides all-flash data storage hardware and software that helps organizations manage their data more efficiently across on-premises and cloud environments.
Why Is P a Top Pick?
- Offerings are pivotal for their customers’ operations as its ARR has averaged 19.3% growth over the past two years
- Earnings per share grew by 61.1% annually over the last five years, massively outpacing its peers
- Strong free cash flow margin of 17.5% enables it to reinvest or return capital consistently
Everpure is trading at $89.50 per share, or 34.5x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
